Cargando…
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
AIMS: Over the last decades, the profile of chronic coronary syndrome has changed substantially. We aimed to determine characteristics and management of patients with chronic coronary syndrome in the contemporary era, as well as outcomes and their determinants. METHODS AND RESULTS: Data from 32 703...
Autores principales: | Sorbets, Emmanuel, Fox, Kim M, Elbez, Yedid, Danchin, Nicolas, Dorian, Paul, Ferrari, Roberto, Ford, Ian, Greenlaw, Nicola, Kalra, Paul R, Parma, Zofia, Shalnova, Svetlana, Tardif, Jean-Claude, Tendera, Michal, Zamorano, José Luis, Vidal-Petiot, Emmanuelle, Steg, Philippe Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964227/ https://www.ncbi.nlm.nih.gov/pubmed/31504434 http://dx.doi.org/10.1093/eurheartj/ehz660 |
Ejemplares similares
-
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2018) -
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
por: Sorbets, Emmanuel, et al.
Publicado: (2019) -
Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017) -
Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2019) -
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome:
the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022)